CD8A and neoplasm: There is also mounting evidence that these cells play a central role in immune tolerance to tumor cells by several mechanisms, including inhibiting effector cytotoxic T-cell lymphocytes by reversibly interfering with the release of lytic granules by CD8+ T cells, thereby impeding target cell lysis [3].